INSPIRE-2, NCT05268939: Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 |
|
|
| Completed | N/A | 668 | US | LumiraDx SARS-CoV-2 & Flu A/B test, LumiraDx SARS-CoV-2 & RSV test | LumiraDx UK Limited | COVID-19, Influenza A, Influenza Type B, RSV Infection | 04/22 | 03/23 | | |